Webster J C, Jewell C M, Bodwell J E, Munck A, Sar M, Cidlowski J A
Molecular Endocrinology Group, the Laboratory of Signal Transduction, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.
J Biol Chem. 1997 Apr 4;272(14):9287-93. doi: 10.1074/jbc.272.14.9287.
Although studies have shown that the mouse glucocorticoid receptor (mGR) contains eight phosphorylation sites (Bodwell, J. E., Ortí, E. , Coull, J. M., Pappin, D. J. C., Smith, L. I., and Swift, F. (1991) J. Biol. Chem. 266, 7549-7555), the effect of phosphorylation on receptor function is unclear. We have examined the consequences of single or multiple phosphorylation site mutations on several properties of mGR including receptor expression, ligand-dependent nuclear translocation, hormone-mediated transactivation, ligand-dependent down-regulation of mGR, and receptor protein half-life. Mutations had little effect on receptor expression, subcellular distribution, ligand-dependent nuclear translocation, or on the ability to activate hormone-mediated transcription from a complex (murine mammary tumor virus) promoter. In contrast, the phosphorylation status of the mGR had a profound effect on the ability to transactivate a minimal promoter containing simple glucocorticoid response elements after hormone administration. Similarly, ligand-dependent down-regulation by glucocorticoids of both receptor mRNA and protein was abrogated in mutants containing three or more phosphorylation site alterations. Finally, we show that the phosphorylation status of mGR has a profound effect on the stability of the glucocorticoid receptor protein. Receptors containing seven or eight mutated sites have a markedly extended half-life and do not show the ligand-dependent destabilization seen with wild type receptor. These data show that receptor phosphorylation may play a crucial role in regulating receptor levels and hence control receptor functions.
尽管研究表明小鼠糖皮质激素受体(mGR)含有八个磷酸化位点(博德韦尔,J.E.,奥尔蒂,E.,库尔,J.M.,帕平,D.J.C.,史密斯,L.I.,以及斯威夫特,F.(1991年)《生物化学杂志》266卷,7549 - 7555页),但磷酸化对受体功能的影响尚不清楚。我们已经研究了单个或多个磷酸化位点突变对mGR多种特性的影响,包括受体表达、配体依赖性核转位、激素介导的反式激活、mGR的配体依赖性下调以及受体蛋白半衰期。突变对受体表达、亚细胞分布、配体依赖性核转位或从复杂(鼠乳腺肿瘤病毒)启动子激活激素介导转录的能力影响很小。相比之下,激素给药后,mGR的磷酸化状态对激活含有简单糖皮质激素反应元件的最小启动子的反式激活能力有深远影响。同样,在含有三个或更多磷酸化位点改变的突变体中,糖皮质激素对受体mRNA和蛋白的配体依赖性下调被消除。最后,我们表明mGR的磷酸化状态对糖皮质激素受体蛋白的稳定性有深远影响。含有七个或八个突变位点的受体半衰期明显延长,并且没有显示出野生型受体所具有的配体依赖性不稳定现象。这些数据表明受体磷酸化可能在调节受体水平从而控制受体功能方面发挥关键作用。